DE1246167B - Verfahren zur Herstellung von Influenza-Vaccinen - Google Patents

Verfahren zur Herstellung von Influenza-Vaccinen

Info

Publication number
DE1246167B
DE1246167B DEB76450A DEB0076450A DE1246167B DE 1246167 B DE1246167 B DE 1246167B DE B76450 A DEB76450 A DE B76450A DE B0076450 A DEB0076450 A DE B0076450A DE 1246167 B DE1246167 B DE 1246167B
Authority
DE
Germany
Prior art keywords
mouse
viruses
passages
virus
mice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DEB76450A
Other languages
German (de)
English (en)
Inventor
Dr Med Kurt Herzberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Siemens Healthcare Diagnostics GmbH Germany
Original Assignee
Behringwerke AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE662899D priority Critical patent/BE662899A/xx
Application filed by Behringwerke AG filed Critical Behringwerke AG
Priority to DEB76450A priority patent/DE1246167B/de
Priority to LU48383A priority patent/LU48383A1/xx
Priority to US448855A priority patent/US3422187A/en
Priority to CH543765A priority patent/CH479700A/de
Priority to AT361165A priority patent/AT259760B/de
Priority to GB16555/65A priority patent/GB1099555A/en
Priority to DK201165AA priority patent/DK110208C/da
Priority to SE5156/65A priority patent/SE308575B/xx
Priority to FR1590063D priority patent/FR1590063A/fr
Priority to FI650983A priority patent/FI41428C/fi
Priority to NL6505122A priority patent/NL6505122A/xx
Priority to BR169124/65A priority patent/BR6569124D0/pt
Publication of DE1246167B publication Critical patent/DE1246167B/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DEB76450A 1964-04-22 1964-04-22 Verfahren zur Herstellung von Influenza-Vaccinen Pending DE1246167B (de)

Priority Applications (13)

Application Number Priority Date Filing Date Title
BE662899D BE662899A (enExample) 1964-04-22
DEB76450A DE1246167B (de) 1964-04-22 1964-04-22 Verfahren zur Herstellung von Influenza-Vaccinen
LU48383A LU48383A1 (enExample) 1964-04-22 1965-04-13
US448855A US3422187A (en) 1964-04-22 1965-04-16 Influenza vaccines and process for their manufacture
CH543765A CH479700A (de) 1964-04-22 1965-04-20 Verfahren zur Gewinnung einer zur Herstellung von Influenzavaccinen geeigneten virushaltigen Allantoisflüssigkeit
AT361165A AT259760B (de) 1964-04-22 1965-04-20 Verfahren zur Herstellung von Influenzavaccinen
GB16555/65A GB1099555A (en) 1964-04-22 1965-04-20 Process for the manufacture of influenza vaccines
DK201165AA DK110208C (da) 1964-04-22 1965-04-21 Fremgangsmåde til fremstilling af influenza-vacciner.
SE5156/65A SE308575B (enExample) 1964-04-22 1965-04-21
FR1590063D FR1590063A (enExample) 1964-04-22 1965-04-22
FI650983A FI41428C (fi) 1964-04-22 1965-04-22 Influenssa-rokotteen valmistusmenetelmä
NL6505122A NL6505122A (enExample) 1964-04-22 1965-04-22
BR169124/65A BR6569124D0 (pt) 1964-04-22 1965-04-22 Aperfeicoamento em processo para a preparacao de vacinado contra a gripe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB76450A DE1246167B (de) 1964-04-22 1964-04-22 Verfahren zur Herstellung von Influenza-Vaccinen

Publications (1)

Publication Number Publication Date
DE1246167B true DE1246167B (de) 1967-08-03

Family

ID=6979080

Family Applications (1)

Application Number Title Priority Date Filing Date
DEB76450A Pending DE1246167B (de) 1964-04-22 1964-04-22 Verfahren zur Herstellung von Influenza-Vaccinen

Country Status (13)

Country Link
US (1) US3422187A (enExample)
AT (1) AT259760B (enExample)
BE (1) BE662899A (enExample)
BR (1) BR6569124D0 (enExample)
CH (1) CH479700A (enExample)
DE (1) DE1246167B (enExample)
DK (1) DK110208C (enExample)
FI (1) FI41428C (enExample)
FR (1) FR1590063A (enExample)
GB (1) GB1099555A (enExample)
LU (1) LU48383A1 (enExample)
NL (1) NL6505122A (enExample)
SE (1) SE308575B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4085203A (en) * 1972-04-26 1978-04-18 Burroughs Wellcome Co. Process for preparing vaccine
JPS6147186A (ja) * 1984-08-09 1986-03-07 Chemo Sero Therapeut Res Inst インフルエンザウイルスの精製方法
GB8703696D0 (en) * 1987-02-18 1987-03-25 Oxford J S Influenza vaccine
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
US9476123B2 (en) 2005-05-31 2016-10-25 Aspen Aerogels, Inc. Solvent management methods for gel production
US20060270248A1 (en) * 2005-05-31 2006-11-30 Gould George L Solvent Management Methods for Gel Production

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
None *

Also Published As

Publication number Publication date
BR6569124D0 (pt) 1973-09-20
GB1099555A (en) 1968-01-17
SE308575B (enExample) 1969-02-17
BE662899A (enExample)
LU48383A1 (enExample) 1966-10-13
AT259760B (de) 1968-02-12
FI41428B (enExample) 1969-07-31
CH479700A (de) 1969-10-15
NL6505122A (enExample) 1965-10-25
FR1590063A (enExample) 1970-04-13
DK110208C (da) 1970-12-21
FI41428C (fi) 1969-11-10
US3422187A (en) 1969-01-14

Similar Documents

Publication Publication Date Title
DE69327307T2 (de) Herstellung von antigenen und impfstoffen vom mysterie-disease-virus, antigene und erworbene impfstoffe zur verhinderung dieser krankheit
EP0304786A2 (de) Intranasale Impfung von Pferden mit inaktivierten Mikroorganismen oder antigenem Material
DE2708668A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2817891A1 (de) Nd-impfstoff und verfahren zu seiner herstellung
DE2713371C2 (enExample)
DE69216732T2 (de) Impfstoff gegen den Geflügelanämieerreger
DE2463143C2 (de) Polyvalente Rindervirus-Lebendimpfstoffe
DE2717919A1 (de) Verfahren zur herstellung eines pferde-rhinopneumonievakzins und durch dieses verfahren hergestelltes vakzin
DE1246167B (de) Verfahren zur Herstellung von Influenza-Vaccinen
DE2362067C2 (de) Temperaturempfindliche, nicht-pathogene, infektiöse Rinder-Rhinotracheitis-Virusstämme, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Lebendimpfstoffen
DD232822A5 (de) Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit
DE69306934T2 (de) Geflügelkrankheit verursachende neue bakterie und daraus stammender impfstoff
DE1198489B (de) Verfahren zur Herstellung eines Impfstoffes gegen Panleucopenie
DE3122669A1 (de) "verfahren zur herstellung von neuen mutanten von herpes simplex-viren typ 1 und typ 2"
DE2445819A1 (de) Verfahren zur herstellung stabiler, gegen seruminhibitoren resistenter h tief 3 n tief 2 -influenzavirusstaemme und diese virusstaemme enthaltende vakzinen
DE2262427C3 (de) Immunostimulierendes Mittel
CH423095A (de) Verfahren zur Herstellung eines Tollwutimpfstoffes
DE2058645C2 (de) Verfahren zur Herstellung eines stark abgeschwächten Newcastle-Disease-Virus-Lebendimpfstoffs
DE1617756A1 (de) Verfahren zur Herstellung einer neuen Antivirusvaccine
DE2415353A1 (de) Verfahren zur herstellung von temperaturempfindlichen, nicht pathogenen mutanten von herpes simplex typ 2-viren und ihre verwendung zur herstellung von vaccinen
DE191752C (enExample)
DE2165401C3 (de) Inaktivierter Kombinationsimpfstoff zum Immunisieren von Geflügel gegen Infektion der Atmungsorgane
DE885466C (de) Verfahren zur Herstellung eines Impfstoffes gegen Schlafkrankheit
DE2162013C3 (de) Tollwut-Lebendimpfstoff, Verfahren zu seiner Herstellung nd seine Verwendung bei der Bekämpfung von Tollwut
DE2747662A1 (de) Poliomyelitis-vaccine